Ryan Dietz
Corporate Officer/Principal at Florida State University
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Shane Burgess | M | - |
Treadwell Therapeutics, Inc.
 Treadwell Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Treadwell Therapeutics, Inc. operates as a clinical-stage oncology firm. It develops small molecules designed to leverage world-class, innovative science in cancer biology and immune-oncology with pan-cancer potential, including hematological malignancies from the TIO Discovery development engine. The company was founded by Tak Wah Mak and Mark R. Bray in July 2019 and is headquartered in New York, NY.
Tio Bioventures
 Tio Bioventures Investment ManagersFinance Tio Bioventures (Tio Bioventures) is a venture capital firm founded in 2019 by Tak Wah Mak and Shane Burgess. The firm is headquartered in New York. | 6 years |
| Mark Bray | M | 58 |
Tio Bioventures
Tio Bioventures Investment ManagersFinance Tio Bioventures (Tio Bioventures) is a venture capital firm founded in 2019 by Tak Wah Mak and Shane Burgess. The firm is headquartered in New York.
Treadwell Therapeutics, Inc.
Treadwell Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Treadwell Therapeutics, Inc. operates as a clinical-stage oncology firm. It develops small molecules designed to leverage world-class, innovative science in cancer biology and immune-oncology with pan-cancer potential, including hematological malignancies from the TIO Discovery development engine. The company was founded by Tak Wah Mak and Mark R. Bray in July 2019 and is headquartered in New York, NY. | 5 years |
| Michael W. Tusche | M | - |
Treadwell Therapeutics, Inc.
Treadwell Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Treadwell Therapeutics, Inc. operates as a clinical-stage oncology firm. It develops small molecules designed to leverage world-class, innovative science in cancer biology and immune-oncology with pan-cancer potential, including hematological malignancies from the TIO Discovery development engine. The company was founded by Tak Wah Mak and Mark R. Bray in July 2019 and is headquartered in New York, NY.
Tio Bioventures
Tio Bioventures Investment ManagersFinance Tio Bioventures (Tio Bioventures) is a venture capital firm founded in 2019 by Tak Wah Mak and Shane Burgess. The firm is headquartered in New York. | - |
| Bill Smith | M | 70 |
Florida State University
| - |
| Tak-Wah Mak | M | 77 |
Tio Bioventures
Tio Bioventures Investment ManagersFinance Tio Bioventures (Tio Bioventures) is a venture capital firm founded in 2019 by Tak Wah Mak and Shane Burgess. The firm is headquartered in New York. | - |
| Roger Sidhu | M | 48 |
Treadwell Therapeutics, Inc.
Treadwell Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Treadwell Therapeutics, Inc. operates as a clinical-stage oncology firm. It develops small molecules designed to leverage world-class, innovative science in cancer biology and immune-oncology with pan-cancer potential, including hematological malignancies from the TIO Discovery development engine. The company was founded by Tak Wah Mak and Mark R. Bray in July 2019 and is headquartered in New York, NY. | - |
| Joseph Travis | M | - |
Florida State University
| - |
| Isan Chen | M | 61 |
Treadwell Therapeutics, Inc.
Treadwell Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Treadwell Therapeutics, Inc. operates as a clinical-stage oncology firm. It develops small molecules designed to leverage world-class, innovative science in cancer biology and immune-oncology with pan-cancer potential, including hematological malignancies from the TIO Discovery development engine. The company was founded by Tak Wah Mak and Mark R. Bray in July 2019 and is headquartered in New York, NY. | - |
| F. L. Hagenbeck | M | - |
Florida State University
| - |
| Angela Santone | F | - |
Florida State University
| - |
| Drew Weatherford | M | - |
Florida State University
| 3 years |
| Philip Duong | M | 34 |
Treadwell Therapeutics, Inc.
Treadwell Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Treadwell Therapeutics, Inc. operates as a clinical-stage oncology firm. It develops small molecules designed to leverage world-class, innovative science in cancer biology and immune-oncology with pan-cancer potential, including hematological malignancies from the TIO Discovery development engine. The company was founded by Tak Wah Mak and Mark R. Bray in July 2019 and is headquartered in New York, NY. | - |
| Hector A. Perez | M | - |
Florida State University
| - |
| Joe Gruters | M | - |
Florida State University
| - |
| Kathryn Ballard | F | - |
Florida State University
| - |
| Stefano Cavallaro | M | - |
Florida State University
| - |
| Emily Duda | F | - |
Florida State University
| - |
| Kristine Harper | F | - |
Florida State University
| - |
| Adam Ely | M | - |
Florida State University
| 6 years |
| John Dubard | M | - |
Florida State University
| - |
| Jorge Gonzalez | M | 59 |
Florida State University
| - |
| Kathleen B. Atkins-Gunter | F | 80 |
Florida State University
| - |
| John Dasburg | M | 81 |
Florida State University
| - |
| Norman E. Thagard | M | 80 |
Florida State University
| - |
| Jeffrey P. Rohr | M | 73 |
Florida State University
| - |
| Lisa M. Getson | F | - |
Florida State University
| - |
| Manuel A. Garcia | M | 80 |
Florida State University
| - |
| Daniel Bass | M | 57 |
Florida State University
| - |
| Michael W. Forsthoefel | M | 69 |
Florida State University
| - |
| Timothy A. Cole | M | 66 |
Florida State University
| - |
| Josh R. Simmons | M | 49 |
Florida State University
| - |
| Stephen R. Winn | M | - |
Florida State University
| - |
| Cherie Pritchard | F | - |
Florida State University
| - |
| Moon-Hi Han | M | - |
Florida State University
| - |
| N. Terry Godbold | M | - |
Florida State University
| 32 years |
| Randall Hanna | M | 65 |
Florida State University
| 8 years |
| Thomas M. McAlpin | M | - |
Florida State University
| - |
| Eric Chicken | M | - |
Florida State University
| - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Rachel Humphrey | M | 62 |
Tio Bioventures
Tio Bioventures Investment ManagersFinance Tio Bioventures (Tio Bioventures) is a venture capital firm founded in 2019 by Tak Wah Mak and Shane Burgess. The firm is headquartered in New York.
Treadwell Therapeutics, Inc.
Treadwell Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Treadwell Therapeutics, Inc. operates as a clinical-stage oncology firm. It develops small molecules designed to leverage world-class, innovative science in cancer biology and immune-oncology with pan-cancer potential, including hematological malignancies from the TIO Discovery development engine. The company was founded by Tak Wah Mak and Mark R. Bray in July 2019 and is headquartered in New York, NY. | - |
| Stephanie Caponigro | F | - |
Suffolk University
| 8 years |
| Tom Howell | M | - |
Indiana University Bloomington
| 9 years |
| Tanya Stavreva | F | - |
Suffolk University
| 5 years |
| Ken Duffel | M | - |
Boston University
| 3 years |
| Lin Shen | M | - |
Boston University
| 2 years |
| Chalermchai Mahagitsiri | M | 46 |
Suffolk University
Boston University
| 6 years |
| Douglas Ryan Mark | M | - |
Boston University
| 4 years |
| Matt Conroy | M | - |
Suffolk University
| 3 years |
| Yamen Al-Hajjar | M | - |
Boston University
| 4 years |
| Eric London | M | - |
Boston University
| 2 years |
| Foy Savas | M | - |
Boston University
| 3 years |
| Michael Solana | M | - |
Boston University
| 4 years |
| Erin Lang | M | 39 |
Boston University
| 4 years |
| Sarah Colbert | F | 43 |
Suffolk University
| 3 years |
| Chris Sznewajs | M | - |
Indiana University Bloomington
| 4 years |
| Robert D. Anstine | M | - |
Boston University
| 3 years |
| Ben Li | M | - |
Suffolk University
| 2 years |
| Jeffrey D. Mowery | M | - |
Treadwell Therapeutics, Inc.
Treadwell Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Treadwell Therapeutics, Inc. operates as a clinical-stage oncology firm. It develops small molecules designed to leverage world-class, innovative science in cancer biology and immune-oncology with pan-cancer potential, including hematological malignancies from the TIO Discovery development engine. The company was founded by Tak Wah Mak and Mark R. Bray in July 2019 and is headquartered in New York, NY. | - |
| Debra Feldman | F | 54 |
Boston University
| 1 years |
| Kevin J. Amell | M | - |
Suffolk University
| 2 years |
| Erik Brue | M | - |
Boston University
| 3 years |
| Megan Lindhe | F | - |
Boston University
| 4 years |
| Subir Lohani | M | 37 |
Boston University
| 4 years |
| Arup Chakrabarti | M | - |
Boston University
| 4 years |
| Stefanie Ng | F | - |
Boston University
| 4 years |
| Mustafa Erdin | M | 55 |
Boston University
| 1 years |
| Rosedel Davies-Adewebi | F | - |
Boston University
| 4 years |
| Monique Austin | F | - |
Boston University
| - |
| Lisa Green | F | - |
Boston University
| 4 years |
| Kimberly Johanson | F | - |
Boston University
| 4 years |
| Jeffrey Humpherys | M | - |
Indiana University Bloomington
| 7 years |
| Kevin Blitz | M | - |
Indiana University Bloomington
| 4 years |
| David Lius | M | 42 |
Suffolk University
| 4 years |
| Mark Holland | M | - |
Boston University
| 4 years |
| Dareen Abdul Aziz Hijazi | F | 44 |
Suffolk University
| 4 years |
| Simona Mocuta | F | - |
Suffolk University
| 2 years |
| Anthony King | M | - |
Boston University
| 3 years |
| Chuck LeVine | M | - |
Suffolk University
| 2 years |
| Timothy A. Schlock | M | - |
Boston University
| 4 years |
| Cel Kulasekaran | M | - |
Boston University
| 1 years |
| Brett Jenkins | M | 53 |
Boston University
| 2 years |
| Kyle Lattner | M | 38 |
Boston University
| 4 years |
| Brad Damon | M | - |
Boston University
| 4 years |
| Anthony Annino | M | - |
Suffolk University
| 8 years |
| Faisal bin Abdul Aziz Jasem Al-Thani | M | - |
Suffolk University
| 4 years |
| Yu Dong Hou | M | 56 |
Suffolk University
| 1 years |
| Shang Hsiu Koo | M | 43 |
Boston University
| 1 years |
| Joseph Teja | M | - |
Suffolk University
| 3 years |
| Dan Egan | M | 43 |
Boston University
| 4 years |
| Logan Yonavjak | F | - |
Boston University
| 1 years |
| John Lefebvre | M | - |
Boston University
| 2 years |
| Noreen Dillon Walsh | F | 53 |
Suffolk University
| 2 years |
| Shane Clifford | M | - |
Boston University
| 1 years |
| Ryan Bloomer | M | - |
Boston University
| 4 years |
| Adam P. Samansky | M | - |
Suffolk University
| 3 years |
| Leah Bean | F | - |
Boston University
| 1 years |
| Alina Fiskina | F | - |
Boston University
| 4 years |
| Caleb DesRosiers | M | 51 |
Suffolk University
| 4 years |
| Nicole Marie Tremblay | F | - |
Suffolk University
| 3 years |
| David M. Fitzgerald | M | - |
Suffolk University
| 2 years |
| Laura Hill | F | - |
Indiana University Bloomington
| 4 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 100 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Ryan Dietz
- Personal Network